🇺🇸 FDA
Patent

US 6303604

Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase

expired A61PA61P35/00A61P43/00

Quick answer

US patent 6303604 (Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 16 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P35/00, A61P43/00